LEVODOPA IN PARKINSONISM - EFFECTS OF WITHDRAWAL OF ANTICHOLINERGIC DRUGS

被引：50
|
作者：
HUGHES, RC
POLGAR, JG
WEIGHTMAN, D
WALTON, JN
机构：
来源：
BMJ-BRITISH MEDICAL JOURNAL | 1971年 / 2卷 / 5760期
关键词：
D O I：
10.1136/bmj.2.5760.487
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：487 / +
页数：1
相关论文
共 50 条
  • [1] LEVODOPA AND ANTICHOLINERGIC DRUGS IN PARKINSONISM
    SOURKES, TL
    BRITISH MEDICAL JOURNAL, 1971, 3 (5776): : 703 - &
  • [2] LEVODOPA AND ANTICHOLINERGIC DRUGS IN PARKINSONISM
    BURN, JH
    BRITISH MEDICAL JOURNAL, 1971, 2 (5764): : 773 - &
  • [3] Anticholinergic drugs: response of parkinsonism not responsive to levodopa
    Yamada, H
    Momose, T
    Okada, M
    Kuroiwa, Y
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 72 (01): : 111 - 113
  • [4] ANTICHOLINERGIC DRUGS FOR NICOTINE ADDICTION AND WITHDRAWAL
    不详
    WESTERN JOURNAL OF MEDICINE, 1986, 144 (04): : 479 - 479
  • [5] STABILOGRAPHIC EVALUATION OF ANTICHOLINERGIC AND DOPAMINERGIC DRUGS IN PARKINSONISM
    CERNACEK, J
    BREZNY, I
    JAGR, J
    REVUE NEUROLOGIQUE, 1972, 127 (02) : 302 - 303
  • [6] Anticholinergic drugs for parkinsonism and other movement disorders
    LeWitt, Peter A.
    Hong, Luke
    Moehle, Mark S.
    JOURNAL OF NEURAL TRANSMISSION, 2024, 131 (12) : 1481 - 1494
  • [7] PARKINSONISM AND DEMENTIA - EFFECTS OF LEVODOPA
    RAJPUT, AH
    ROZDILSKY, B
    LANCET, 1975, 1 (7915): : 1084 - 1084
  • [8] Clinical, pharmacokinetic, and pharmacodynamic effects of tolcapone withdrawal in levodopa-treated patients with parkinsonism
    Jorga, KM
    Davis, TL
    Kurth, MC
    Saint-Hilaire, MH
    LeWitt, PA
    Fotteler, B
    Zürcher, G
    Rabbia, M
    CLINICAL NEUROPHARMACOLOGY, 2000, 23 (02) : 98 - 105
  • [9] PARKINSONISM AND DEMENTIA - EFFECTS OF LEVODOPA
    PEARCE, J
    PEARCE, I
    LANCET, 1975, 1 (7918): : 1245 - 1245
  • [10] ANTICHOLINERGIC EQUIVALENTS AND PARKINSONISM - A MODEL FOR PREDICTING SIDE-EFFECTS OF ANTIPSYCHOTIC-DRUGS
    MENKES, DB
    CLARKSON, HO
    CARADOCDAVIES, G
    MULLEN, PE
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1987, 2 (01) : 55 - 67
12345